Statistics indicate that the highest expenditure within the past five years via Aasandha coverage was on cases of Type 2 diabetes and hypertension.
Statistics indicate that the highest expenditure within the past five years via Aasandha coverage was on cases of Type 2 diabetes and hypertension.
In 2019, MVR 39.8 million was spent via Assandha on treatment of hypertension cases, with the number rising to MVR 78.7 million in 2020.
In 2021, MVR 101 million was spent on treatment of Type 2 diabetes. The number increased to MVR 152.9 million in 2022, and MVR 164.7 million in 2023.
Between 2019 and 2023, the next highest spending was on kidney diseases, high cholesterol levels and common cold.
In the past five years:
- MVR 517 million was spent on diabetes cases
- MVR 449 million was spent on hypertension cases
- MVR 177 million was spent on cases of high cholesterol levels
- MVR 116 million was spent on cases of kidney diseases
- MVR 113 million was spent on cases of common cold
Aasandha said that MVR 7.8 billion had been spent on treatment of ailments within the past five years, with an addition MVR 4.4 billion spent on prescriptions.
Sign In
